Asker Healthcare Group AB (publ) (STO:ASKER)
Sweden · Delayed Price · Currency is SEK 74.40
-0.30 (-0.40%)
Aug 26, 2026, 5:29 PM CET
Asker Healthcare Group AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 684 | 492 | 360 | 203 | 430 | 467 |
Depreciation & Amortization | 902 | 752 | 548 | 502 | 341 | 185 |
Other Amortization | 62 | 62 | 60 | 46 | 54 | 45 |
Loss (Gain) From Sale of Assets | - | - | - | 1 | - | - |
Other Operating Activities | -43 | 15 | 300 | 179 | 118 | -108 |
Change in Accounts Receivable | 88 | -87 | 292 | -217 | -22 | 239 |
Change in Inventory | -43 | 53 | -144 | 21 | -12 | -181 |
Change in Other Net Operating Assets | -131 | 41 | -189 | 317 | 67 | -265 |
Operating Cash Flow | 1,519 | 1,328 | 1,227 | 1,052 | 976 | 382 |
Operating Cash Flow Growth | 51.60% | 8.23% | 16.63% | 7.79% | 155.50% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -524 | -590 | -348 | -151 | -123 | -124 |
Sale of Property, Plant & Equipment | 62 | 15 | - | - | 1 | - |
Cash Acquisitions | -1,856 | -2,331 | -1,109 | -632 | -1,738 | -719 |
Investing Cash Flow | -2,318 | -2,906 | -1,457 | -783 | -1,860 | -843 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 59 | 126 | - | - | - |
Long-Term Debt Issued | - | 5,098 | 467 | 77 | 902 | 858 |
Total Debt Issued | 976 | 5,157 | 593 | 77 | 902 | 858 |
Long-Term Debt Repaid | - | -4,548 | -296 | -219 | -734 | -235 |
Net Debt Issued (Repaid) | 425 | 609 | 297 | -142 | 168 | 623 |
Issuance of Common Stock | - | 1,407 | - | 63 | 399 | 1 |
Other Financing Activities | -16 | 9 | 8 | -4 | 5 | -5 |
Financing Cash Flow | 260 | 2,025 | 305 | -83 | 572 | 619 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -8 | -53 | 24 | -5 | 29 | 3 |
Miscellaneous Cash Flow Adjustments | -1 | - | - | -1 | - | - |
Net Cash Flow | -548 | 394 | 99 | 180 | -283 | 161 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 995 | 738 | 879 | 901 | 853 | 258 |
Free Cash Flow Growth | 98.60% | -16.04% | -2.44% | 5.63% | 230.62% | - |
Free Cash Flow Margin | 5.52% | 4.40% | 5.85% | 6.70% | 7.28% | 2.76% |
Free Cash Flow Per Share | 2.60 | 2.00 | 2.73 | 3.44 | 3.30 | 1.09 |
Levered Free Cash Flow | 534.38 | 767.25 | 478.5 | 698 | 400.38 | - |
Unlevered Free Cash Flow | 624.38 | 899.13 | 667.25 | 863 | 516.63 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 214 | 201 | 228 | 192 | 95 | - |
Cash Income Tax Paid | 297 | 337 | 201 | 126 | 100 | 85 |
Change in Working Capital | -86 | 7 | -41 | 121 | 33 | -207 |